13F-HR filed by HARVARD MANAGEMENT CO INC
HARVARD MANAGEMENT CO INC filed this 13F-HR for the quarter ended 2022-06-30, filed 2022-08-12, with 45 holding rows worth $863,762,000.
- Accession
- 0000950123-22-008784
- Filer
- CIK 1082621
- Filed
- 2022-08-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2022
A holdings report, 45 entries on the cover page, a total value of $863,762,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $863,763,000 with VALUE read as thousands by filing date, 13F file number 028-03879. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Alphabet Inc. Reg. Shares A | 02079K305 | COM | 120,577 | $262,769,000 | thousands by filing date | |
| META PLATFORMS INC CL A | 30303M102 | COM | 1,135,916 | $183,166,000 | thousands by filing date | |
| LIGHT & WONDER INC COM | 80874P109 | Stock | 2,678,571 | $125,866,000 | thousands by filing date | |
| ABCELLERA BIOLOGICS INC COM | 00288U106 | Stock | 4,105,095 | $43,719,000 | thousands by filing date | |
| EQRX INC | 26886C107 | COM | 5,262,161 | $24,680,000 | thousands by filing date | |
| PURECYCLE TECHNOLOGIES INC | 74623V103 | COM | 2,498,170 | $18,536,000 | thousands by filing date | |
| GRABHLDGSLTDFCLASSCLASSA | G4124C109 | STOK | 5,369,919 | $13,586,000 | thousands by filing date | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 670,382 | $13,066,000 | thousands by filing date | |
| RECURSION PHARMACEUTICALS IN | 75629V104 | CL A | 1,509,254 | $12,285,000 | thousands by filing date | |
| NVIDIA Corp | 67066G104 | COM | 66,368 | $10,061,000 | thousands by filing date | |
| MELI KASZEK PIONEER CORP | G5S74L106 | CLASS A ORD | 1,000,000 | $9,900,000 | thousands by filing date | |
| QORVO INC COM | 74736K101 | Stock | 104,669 | $9,872,000 | thousands by filing date | |
| ASMLHLDGNVFSPONSOREDADR1ADRREPS1ORDSHS | N07059210 | STOK | 20,186 | $9,606,000 | thousands by filing date | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 541,124 | $9,064,000 | thousands by filing date | |
| TAIWAN SEMICONDUCTOR MFG | 874039100 | SPONSORED ADS | 107,294 | $8,771,000 | thousands by filing date | |
| Advanced Micro Devices,Inc. | 007903107 | COM | 112,137 | $8,575,000 | thousands by filing date | |
| 10X GENOMICS INC CL A COM | 88025U109 | Stock | 186,143 | $8,423,000 | thousands by filing date | |
| LAM RESEARCH CORP | 512807108 | COM | 19,131 | $8,153,000 | thousands by filing date | |
| Applied Materials,Inc. | 038222105 | COM | 88,443 | $8,047,000 | thousands by filing date | |
| Analog Devices,Inc. | 032654105 | COM | 54,568 | $7,972,000 | thousands by filing date | |
| Intel Corp | 458140100 | COM | 207,752 | $7,772,000 | thousands by filing date | |
| KINNATE BIOPHARMA INC | 49705R105 | COM | 498,001 | $6,280,000 | thousands by filing date | |
| Micron Technology,Inc. | 595112103 | COM | 107,522 | $5,944,000 | thousands by filing date | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 562,379 | $4,505,000 | thousands by filing date | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 314,762 | $3,988,000 | thousands by filing date | |
| TENAYA THERAPEUTICS INC | 87990A106 | COM | 673,270 | $3,791,000 | thousands by filing date | |
| ROCKET LAB USA INC | 773122106 | COM | 1,000,000 | $3,790,000 | thousands by filing date | |
| GENERATION BIO CO | 37148K100 | COM | 510,354 | $3,348,000 | thousands by filing date | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 708,385 | $3,209,000 | thousands by filing date | |
| AFFIRM HLDGS INC COM CL A | 00827B106 | Stock | 173,560 | $3,134,000 | thousands by filing date | |
| CONFLUENT INC | 20717M103 | CLASS A COM | 130,383 | $3,030,000 | thousands by filing date | |
| SANA BIOTECHNOLOGY INC | 799566104 | COM | 468,749 | $3,014,000 | thousands by filing date | |
| Surrozen, Inc. | 86889P109 | COM | 826,852 | $2,431,000 | thousands by filing date | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 410,714 | $2,012,000 | thousands by filing date | |
| PRAXIS PRECISION MEDICINES I | 74006W108 | COM | 778,517 | $1,907,000 | thousands by filing date | |
| PURECYCLE TECHNOLOGIES INC | 74623V111 | *W EXP 03/17/202 | 714,285 | $1,893,000 | thousands by filing date | |
| DECIBEL THERAPEUTICS INC | 24343R106 | COM | 328,798 | $1,384,000 | thousands by filing date | |
| PARDES BIOSCIENCES INC | 69945Q105 | COM | 400,000 | $1,228,000 | thousands by filing date | |
| Xilio Therapeutics Inc. | 98422T100 | COM | 416,059 | $1,215,000 | thousands by filing date | |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 229,144 | $1,013,000 | thousands by filing date | |
| VIGIL NEUROSCIENCE INC | 92673K108 | COM | 289,460 | $747,000 | thousands by filing date | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 107,252 | $737,000 | thousands by filing date | |
| SERES THERAPEUTICS INC | 81750R102 | COM | 131,847 | $452,000 | thousands by filing date | |
| GEMINI THERAPEUTICS INC | 36870G105 | CMN | 250,000 | $423,000 | thousands by filing date | |
| DIANTHUS THERAPEUTICS INC COM | 55910K108 | Stock | 332,610 | $399,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-22-008784 | this filing | 2022-08-12 | acceptance time not in the bulk data set |